Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · BOROSIL SCIENTIFIC LTD · 29 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
BOROSIL SCIENTIFIC LTD
NSE: BOROSCI · BSE: 544184
NSE: BOROSCI · BSE: 544184
Industrials › Capital Goods › Industrial Products › Glass - Industrial
BOROSIL SCIENTIFIC LTD
StateQ1 FY27 filed
Last close · 28 Oct 2026₹109.95
Market cap₹1.0k cr
TTM P/E · P/B · EV/EBITDA22.7 · 2.21 · 13.3
BOROSIL SCIENTIFIC LTD is a Industrial Products company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY24–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 395 | 438 | 467 |
| EBITDA (ex other income) | 45 | 53 | 54 |
| margin % | 11.5 | 12.0 | 11.5 |
| Owners' profit | 24 | 27 | 35 |
| EPS, as reported (₹) | 2.65 | 3.02 | 3.89 |
| ROE % · ROCE % | 6.2 · 8.7 | 6.6 · 9.9 | 7.8 · 9.6 |
| Debt / equity (x) | 0.04 | 0.03 | 0.02 |
| Cash from operations | 30 | 120 | 43 |
| Capex | (13) | (14) | (28) |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · BOROSIL SCIENTIFIC LTD · 29 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 101 | 129 | 96 | 107 | 121 | 143 | 107 |
| Profit before tax | 12 | 7 | 14 | (4) | 5 | 13 | 29 | 6 |
| Net profit | 9 | 4 | 9 | (4) | 3 | 9 | 27 | 4 |
| EPS (₹) | 0.99 | 0.48 | 0.98 | (0.47) | 0.32 | 0.98 | 3.06 | 0.49 |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Segment revenue, FY26
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Scientific-Laboratory Glass and Equipment and process system | 110 | 23.5 |
| Glassware | 131 | 28.0 |
| Others | 6 | 1.2 |
| Scientific – Laboratory Glass & equipment and Process System | 221 | 47.4 |
| Total, before eliminations | 467 | 100.0 |
Source: the filed segment block, four quarters summed.
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| BOROSIL RENEWABLES LTD | 5,510 | 14.3 | 3.65 | 22.2 | 8.4 | 8.8 | — | 34.8 |
| BOROSIL SCIENTIFIC LTD ◆ | 978 | 22.7 | 2.22 | 15.4 | 7.8 | 9.4 | — | 10.4 |
| AGARWAL FORTUNE INDIA LIMITED | 6 | 104.0 | 8.92 | — | 8.6 | 2.5 | — | 20.8 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 22.7 | 17.6 | 201 of 337 | 41% |
| P/B | 2.2 | 1.9 | 180 of 316 | 43% |
| ROCE | 9.4 | 9.7 | 190 of 373 | 49% |
| ROE | 7.8 | 8.7 | 175 of 322 | 46% |
| Debt / Equity | 0.0 | 0.2 | 70 of 320 | 78% |
| EBITDA margin | 10.4 | 11.9 | 182 of 317 | 43% |
| Revenue growth | 11.2 | 13.7 | 172 of 311 | 45% |
| Profit growth | 203.5 | 25.5 | 50 of 314 | 84% |
| Market cap | 978 | 203 | 117 of 383 | 70% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · BOROSIL SCIENTIFIC LTD · 29 October 2026Page 3 of 3
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 28 Oct 2026 · Consolidated Q2 profit up 86%; H1 turns profitable; Rs 70 crore furnace approved | results | high | — | — |
| 28 Oct 2026 · Q2 profit rises; Rs 70 crore glass tubing furnace approved | results | high | — | — |
| 28 Oct 2026 · Q2 profit after tax up 86%; Board approves Rs 70 crore glass tubing furnace | results | medium | — | — |
| 21 Oct 2026 · Board meeting on Oct 28 to consider Q2/H1 FY26 results | results | low | — | — |
| 6 Oct 2026 · Compliance certificate under SEBI Reg 74(5) for Q2 FY27 | compliance | minimal | — | — |
| 28 Sept 2026 · Intimation for Closure of Trading Window | compliance | minimal | — | — |
| 25 Sept 2026 · All 9 resolutions passed at 35th AGM with strong majority | compliance | minimal | — | — |
| 25 Sept 2026 · 35th AGM held; 9 resolutions tabled including fundraising and ESOP changes | board shareholder meetings | low | — | — |
| 23 Sept 2026 · Borosil Scientific: Operations Head at subsidiary resigns | management changes | high | — | — |
| 22 Sept 2026 · Borosil Scientific approves Rs 60 cr capacity expansion in Bharuch | capex operations | high | — | — |
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in